The University of Cambridge is developing a blood test that could detect a common cancer that kills 12,000 people each year.

Research from the University of Cambridge may be able to start a national screening programme for the common cancer ...

Prostate cancer causes around 12,000 deaths each year but the available tests are unreliable according to experts ...

Preliminary total global full year 2025 revenue of approximately $616 millionPreliminary BRIUMVI U.S. fourth quarter and full year 2025 net ...

Detailed price information for Autolus Therapeutics Plc ADR (AUTL-Q) from The Globe and Mail including charting and trades.

A new discovery about how cells communicate with each other in the body's immune system has revealed deeper insights for an ...

A test that rapidly detects signs of inflammatory bowel disease (IBD) in stool samples could improve future diagnosis and ...

Last year, the Food and Drug Administration approved the first at-home test that can detect three common infections in women ...

Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global ...

The disease was projected to account for 30 per cent of all new cancers among men nationwide. Cancer diagnoses among younger ...

The digital service is set to launch next year and promises faster access to specialists for some common health issues ...

Mirum Pharmaceuticals Announces Preliminary Unaudited 2025 Results, Demonstrating Strong Commercial Growth and Pipeline ...